Protalix Biotherapeutics Inc (PLX) — Cash Flow Reinvestment Rate
Protalix Biotherapeutics Inc (PLX) has a Cash Flow Reinvestment Rate of 0.61x as of December 2025, reinvesting $1.24 Million (capex $1.24 Million ) from operating cash flow of $2.03 Million. See cash generation quality of Protalix Biotherapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protalix Biotherapeutics Inc Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Protalix Biotherapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Protalix Biotherapeutics Inc generate cash.
Annual Cash Flow Reinvestment Rate for Protalix Biotherapeutics Inc (2009–2024)
Year-by-year capital reinvestment analysis for Protalix Biotherapeutics Inc. See financial flexibility index of Protalix Biotherapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | $5.50 Million | $8.67 Million | $1.28 Million | ▼ -80.5% |
| 2012 | 3.26x | $2.07 Million | $635.00K | $2.07 Million | ▲ +2236.8% |
| 2009 | 0.14x | $6.20 Million | $44.45 Million | $6.20 Million | — |